Related Experiment Video
Updated: Jun 16, 2026

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an In Vitro Bioanalytical Method
Published on: September 16, 2017
Tumor necrosis factor, lymphotoxin and cancer
Marina S Drutskaya1, Grigory A Efimov, Andrey A Kruglov
1Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia. marinadru@gmail.com
Tumor necrosis factor (TNF) and lymphotoxins have dual roles in cancer, acting as both anti-tumor and pro-tumorigenic factors. Their complex signaling pathways influence host defense, inflammation, and immune system homeostasis, impacting cancer development and treatment.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Tumor necrosis factor (TNF) was initially identified as an anti-tumor agent but is now recognized for its broad roles in innate immunity and inflammation.
- Dysregulation of TNF signaling can lead to detrimental effects, contributing to treatment failures in oncology and influencing tumor-promoting activities.
- Anti-TNF therapies are effective in autoimmune diseases but carry risks such as immune suppression and potential lymphoma predisposition.
Purpose of the Study:
- To review the dual role of TNF and lymphotoxins in cancer.
- To explore the intricate signaling mechanisms of TNF and lymphotoxins through their receptors.
- To critically assess whether TNF and lymphotoxins are intrinsically anti-cancer or pro-tumorigenic.
Main Methods:
- Literature review of existing research on TNF and lymphotoxin signaling.
- Analysis of experimental models investigating the pro- and anti-tumorigenic effects of TNF.
- Examination of the role of lymphotoxin signaling pathways in immune system development and cancer.
Main Results:
- TNF exhibits context-dependent effects, acting as an anti-tumor factor in some settings and pro-tumorigenic in others, particularly via the TNF-TNFRp55 axis.
- Lymphotoxins (LTs) alpha and beta, signaling through TNFR I, TNFR II, and LTbetaR, are crucial for immune system homeostasis.
- Emerging evidence links the LTalpha/LTbeta-LTbetaR axis to cancer, highlighting its complex involvement.
Conclusions:
- The role of TNF and lymphotoxins in cancer is complex and multifaceted, with both beneficial and detrimental implications.
- Understanding the precise signaling pathways and cellular contexts is crucial for harnessing their therapeutic potential.
- Further research is needed to elucidate the net effect of these cytokines in tumorigenesis and to optimize anti-TNF/LT therapies.
Related Concept Videos
Tumor Immunotherapy
The Tumor Microenvironment
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
lncRNA - Long Non-coding RNAs
The Intrinsic Apoptotic Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
